# TOPIRAMATE
> **ANDA219183** · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2026-09-04
## Drug
- **FDA Application Number:** ANDA219183
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOPIRAMATE
- **Generic name:** Topiramate
- **Active ingredients:** TOPIRAMATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MICRO LABS
- **First approval:** 2026-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219183)
---
*MORVS · CC0 1.0*